I'm LongbridgeAI, I can summarize articles.Retension Pharmaceuticals (RTSN.US) fell nearly 9% during regular trading to $12.32.
The stock is down 15.52% over the past five sessions and sits 33.91% below its 52-week high of US$18.64. The intraday swing reached 11.50%.
The Nasdaq Composite is down 0.73% over the past five sessions and up 14.06% year to date.
Based on public media reports. AI-generated; not investment advice.